Last mentioned: Mar 19, 2026
Consortium Launch
Lunai Bioworks officially announces the National Chemical Defense Consortium.
Lunai Bioworks has established the National Chemical Defense Consortium to bid for U.S. government contracts valued between $400 million and $1.2 billion. The initiative leverages a proprietary three-year AI model designed to radically accelerate the development of antidotes against chemical threats.
Lunai Bioworks (NASDAQ: LNAI) has established the National Chemical Defense Consortium to target U.S. government countermeasure contracts valued up to $1.2 billion. The initiative leverages a proprietary three-year AI-driven development model to accelerate the creation of antidotes for chemical threats.
Lunai Bioworks (NASDAQ: LNAI) has established the National Chemical Defense Consortium to pursue up to $1.2 billion in U.S. defense countermeasure programs. The initiative utilizes a proprietary 3-year AI development model to drastically accelerate the creation of antidotes for chemical threats.